Trials / Conditions / Non-Squamous Non-Small Cell Neoplasm of Lung
Non-Squamous Non-Small Cell Neoplasm of Lung
6 registered clinical trials studyying Non-Squamous Non-Small Cell Neoplasm of Lung.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Liquid Biopsy Based NGS in Newly Diagnosed NSCLC NCT05853887 | Charu Aggarwal | N/A |
| Terminated | NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial NCT04698681 | Calithera Biosciences, Inc | — |
| Terminated | KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, NCT04265534 | Calithera Biosciences, Inc | Phase 2 |
| Completed | Alectinib in Combination With Bevacizumab in ALK Positive NSCLC NCT03779191 | Instituto Nacional de Cancerologia de Mexico | Phase 2 |
| Unknown | Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treat NCT03912389 | Biocad | Phase 3 |
| Completed | Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC NCT03177291 | H. Lee Moffitt Cancer Center and Research Institute | Phase 1 |